Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Furthermore, cannabis smokers were more Vitamin D deficient (p = 0.009) and had a higher serum concentration of hemoglobin (p = 0.005) compared to non-smokers.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This study employed a cross-sectional design to evaluate the prevalence of cannabis use among male hemodialysis patients and to examine the differences in chronic pain characteristics and quality of life between recreational cannabis users and non-users within this population.

Source: Methods.

Cancer patients were excluded from the study due to the overlap and difference in pain physiology between hemodialysis and cancer patients.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Recreational cannabis use in hemodialysis patients: prevalence, chronic pain profile and impact on quality of life

Cross-sectional study · Journal of Cannabis Research · 2026

Original publication title

Recreational cannabis use in hemodialysis patients: prevalence, chronic pain profile and impact on quality of life

Fatima Zahra Bouchachi; Nadia AL Wachami; Younes Iderdar; Maryem Arraji; Karima Boumendil; Chaimaa El Moubchiri; Hasna Zaeria; Abdeljalil El Got; Zineb Serhier; Mohamed Chahboune

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Cannabis smokers were predominantly from rural areas, had a history of tobacco use and were less likely to suffer from chronic pain than non-smokers. The smoker's group had low pain severity and better quality of life compared to non-smokers. However, more research is needed to investigate the relationship of frequency, quantity and quality of cannabis on efficiency and reduction of chronic pain in patients treated by hemodialysis.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Morocco is one of the world's leading suppliers of cannabis, primarily cultivated in its northern region. Smoked cannabis has been reported in the literature to relieve suffering. Pain is a prevalent symptom in hemodialysis patients, leading to decreased quality of life. Therefore, this study aims to determine the prevalence of smoking cannabis in male patients undergoing hemodialysis and to explore the sociodemographic, biological and chronic pain characteristics, and quality of life between users of recreational cannabis and non-users.

Source: Background

Abstract: What methods does the paper describe?

A total of 186 male patients on hemodialysis were recruited from four dialysis centers in the northern Morocco region. The Numeric Rating scale was used to assess pain severity and the Short-Form 36 (SF-36) questionnaire was adopted to evaluate the quality of life. The Brief Pain Inventory was used to locate the painful sites. Data collection utilized medical files and a structured questionnaire including sociodemographic, clinical and dialysis-related variables.

Source: Methods

Abstract: Results

The prevalence of cannabis use was 18.2%. Patients in rural areas and current tobacco smokers use more cannabis. Compared to the non-smokers' group, the smokers' group had less chronic pain (p = 0.002) and lower pain severity (p = 0.006). For the quality of life, significantly higher mean scores in general health, bodily pain and vitality domains (p = 0.02), (p < 0.001) and (p = 0.009) respectively, and increased physical component summary (p = 0.003). Furthermore, cannabis smokers were more Vitamin D deficient (p = 0.009) and had a higher serum concentration of hemoglobin (p = 0.005) compared to non-smokers.

Source: Results

Abstract: Conclusions

Cannabis smokers were predominantly from rural areas, had a history of tobacco use and were less likely to suffer from chronic pain than non-smokers. The smoker's group had low pain severity and better quality of life compared to non-smokers. However, more research is needed to investigate the relationship of frequency, quantity and quality of cannabis on efficiency and reduction of chronic pain in patients treated by hemodialysis.

Source: Conclusions
Authors’ abstract

Background

Morocco is one of the world's leading suppliers of cannabis, primarily cultivated in its northern region. Smoked cannabis has been reported in the literature to relieve suffering. Pain is a prevalent symptom in hemodialysis patients, leading to decreased quality of life. Therefore, this study aims to determine the prevalence of smoking cannabis in male patients undergoing hemodialysis and to explore the sociodemographic, biological and chronic pain characteristics, and quality of life between users of recreational cannabis and non-users.

Methods

A total of 186 male patients on hemodialysis were recruited from four dialysis centers in the northern Morocco region. The Numeric Rating scale was used to assess pain severity and the Short-Form 36 (SF-36) questionnaire was adopted to evaluate the quality of life. The Brief Pain Inventory was used to locate the painful sites. Data collection utilized medical files and a structured questionnaire including sociodemographic, clinical and dialysis-related variables.

Results

The prevalence of cannabis use was 18.2%. Patients in rural areas and current tobacco smokers use more cannabis. Compared to the non-smokers' group, the smokers' group had less chronic pain (p = 0.002) and lower pain severity (p = 0.006). For the quality of life, significantly higher mean scores in general health, bodily pain and vitality domains (p = 0.02), (p < 0.001) and (p = 0.009) respectively, and increased physical component summary (p = 0.003). Furthermore, cannabis smokers were more Vitamin D deficient (p = 0.009) and had a higher serum concentration of hemoglobin (p = 0.005) compared to non-smokers.

Conclusions

Cannabis smokers were predominantly from rural areas, had a history of tobacco use and were less likely to suffer from chronic pain than non-smokers. The smoker's group had low pain severity and better quality of life compared to non-smokers. However, more research is needed to investigate the relationship of frequency, quantity and quality of cannabis on efficiency and reduction of chronic pain in patients treated by hemodialysis.

Publication and source details

Original title: Recreational cannabis use in hemodialysis patients: prevalence, chronic pain profile and impact on quality of life

Fatima Zahra Bouchachi; Nadia AL Wachami; Younes Iderdar; Maryem Arraji; Karima Boumendil; Chaimaa El Moubchiri; Hasna Zaeria; Abdeljalil El Got; Zineb Serhier; Mohamed Chahboune

Journal of Cannabis Research · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:58:52.538076+00:00

DOI: 10.1186/s42238-026-00471-3 · PMC13721554